BeOne Medicines AG (ONC)
NASDAQ: ONC · Real-Time Price · USD
313.77
-2.24 (-0.71%)
At close: Aug 3, 2026, 4:00 PM EDT
313.81
+0.04 (0.01%)
After-hours: Aug 3, 2026, 7:34 PM EDT
BeOne Medicines AG Stock Forecast
Stock Price Forecast
According to 28 analysts polled by S&P Global, BeOne Medicines AG stock has a consensus rating of "Strong Buy" and an average price target of $415.64. The average 1-year stock price forecast is 32.47% higher than the current stock price, while the lowest is $340 (+8.36%) and the highest is $501.3 (+59.77%).
Price Target: $415.64 (+32.47%)
Analyst Consensus: Strong Buy
Price Target
ChartAnalyst Ratings
The average analyst rating for BeOne Medicines AG stock is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | Feb '26 | Mar '26 | Apr '26 | May '26 | Jun '26 | Jul '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 18 | 18 | 18 | 19 | 19 | 20 |
| Buy | 7 | 7 | 7 | 8 | 8 | 8 |
| Hold | 0 | 1 | 1 | 1 | 1 | 0 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 1 | 0 | 0 | 0 | 0 | 0 |
| Total | 26 | 26 | 26 | 28 | 28 | 28 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Morgan Stanley | Morgan Stanley | Buy Maintains $395 | Buy | Maintains | $395 | +25.89% | Jul 23, 2026 |
| J.P. Morgan | J.P. Morgan | Buy Maintains $415 → $425 | Buy | Maintains | $415 → $425 | +35.45% | Jul 23, 2026 |
| Barclays | Barclays | Buy Maintains $409 → $403 | Buy | Maintains | $409 → $403 | +28.44% | Jul 14, 2026 |
| Jefferies | Jefferies | Buy Upgrades $333 → $380 | Buy | Upgrades | $333 → $380 | +21.11% | Jul 13, 2026 |
| Truist Financial | Truist Financial | Buy Maintains $413 → $416 | Buy | Maintains | $413 → $416 | +32.58% | Jul 7, 2026 |
Financial Forecast
Revenue This Year
6.51B
from 5.34B
Increased by 21.81%
Revenue Next Year
7.45B
from 6.51B
Increased by 14.53%
EPS This Year
0.50
from 0.19
Increased by 162.93%
EPS Next Year
0.76
from 0.50
Increased by 52.72%
EPS and Forward PE are based on non-GAAP adjusted numbers.